The Deal Register
Database › Debt financing › Morphocell Technologies Completes US$50 Million Series A Financing

Debt financing

Morphocell Technologies Completes US$50 Million Series A Financing

Lane
Debt financing
Announced
01 Dec 2025
Province
Quebec
Industry
Technology
Status
Announced
What the filing says
Morphocell Technologies Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its US$50 million Series A financing following a US$10 million add-on led by Investissement Québec, the province's leading economic development corporation, and CDP Venture Capital, part of Italy's Cassa Depositi e Prestiti (CDP) group.
Source

The terms are in the subscriber edition

This transaction carries the consideration.

Subscribe

Compiled from public filings, court documents, exchange bulletins and issuer releases. Figures are as disclosed and are not independently verified.

Not financial, investment, legal or tax advice, and not an offer to buy or sell any security. Verify everything before you transact.

The Deal Register · Archive · Subscribe